Stocks to watch: Dr Reddy's, Torrent Pharma, Gensol, L&T Finance, Glenmark
Dr Reddy’s Laboratories: The company has signed a licensing agreement with US-based Ingenus Pharmaceuticals to commercialise Cyclophosphamide injection, a cancer treatment. Under the agreement, Dr Reddy’s will commercialise the injection for the US market and pay Ingenus 50% of the calculated profit share.Torrent Pharmaceuticals: The company announced on Wednesday that it has received a Form 483 with five observations from the US FDA following an inspection of its manufacturing plant in Indrad, Gujarat.Whirlpool of India, Hindustan Unilever: The two companies announced a new marketing alliance for Surf Excel.
According to the alliance, both the brands will have joint marketing initiatives.Gensol Engineering: The company emerged as the successful bidder for Gujarat Urja Vikas Nigam’s 250 MW (500 MWh) Battery Energy Storage Project worth ₹1,340 crore. The project will supply electricity to Gujarat State’s DISCOMs during peak and off-peak hours.L&T Finance: Private equity major Bain Capital is planning to make a complete exit from L&T Finance by selling its existing stake via the block deal route.Glenmark: The company announced on Wednesday that it has received approval from the US FDA to market a generic medication to treat conditions caused by excessive acid production in the stomach.Tata Motors: Jefferies’ latest report states that Tata Motors’ India business, which was a significant drag in the past decade, now forms 50% of the price target set by the brokerage for FY26.
Read more on livemint.com
